On testing for proteinuria: Time for a methodical approach

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 6, 2003, Pages 493-501

  Eknoyan, Garabed ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ALGORITHM; CARDIOVASCULAR RISK; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; EDITORIAL; GLOMERULOPATHY; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; PRACTICE GUIDELINE; PROTEINURIA; QUANTITATIVE ANALYSIS; SCREENING TEST; URINALYSIS;

EID: 0038209296     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.6.493     Document Type: Editorial

References (14)

1. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection and elimination (PARADE). A position paper of the National Kidney Foundation. Am J Kidney Dis 1999; 33:1004-1010.
2. Grimm RH Jr, Sandsen KH, Kasiske B, Keane WM, Wahi M. Proteinuria is a risk factor for mortality over 10 years of follow up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int 1997; 63(suppl 63):S10-S14.
3. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123:754-762.
4. Mutner P, He J, Hamm L, Loria C, Whelton P. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13:745-753.
5. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286:421-426.
6. SoRelle R. Increases in urinary albumin excretion predict risk of death from all causes as well as those from cardiovascular disease. Circulation 2002; 106:e9037-e9038.
7. Leoncini G, Sacchi G, Viazzi F, et al. Microalbuminuria identifies overall cardiovascular risk in essential hypertension. J Hypertens 2002; 20:1315-1321.
8. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in the general population. Circulation 2002; 106:1777-1782.
9. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S, for the HOPE Investigators. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 2001; 134:629-636.
10. Keane WF. Proteinuria: Its clinical importance and role in progressive renal disease. Am J Kidney Dis 2000; 35:(suppl 1):S97-S105.
11. Kashif W, Siddiqi N, Dincer AP, Dincer HE, Hirsch S. Proteinuria: How to evaluate an important finding. Cleve Clin J Med 2003; 70:535-547.
12. Schwab SL, Christensen RL, Dougherty K, Klahr S. Quantification of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med 1987; 147:943-944.
13. Chitalia VC, Kothari J, Wells EJ, et al. Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio. Clin Nephrol 2001; 55:436-447.
14. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39(suppl 1):S25-S27.